GB2328155B - Methods of treating immunopathologies using polyunsaturated fattyacids - Google Patents

Methods of treating immunopathologies using polyunsaturated fattyacids

Info

Publication number
GB2328155B
GB2328155B GB9822203A GB9822203A GB2328155B GB 2328155 B GB2328155 B GB 2328155B GB 9822203 A GB9822203 A GB 9822203A GB 9822203 A GB9822203 A GB 9822203A GB 2328155 B GB2328155 B GB 2328155B
Authority
GB
United Kingdom
Prior art keywords
immunopathologies
fattyacids
polyunsaturated
treating
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB9822203A
Other languages
English (en)
Other versions
GB9822203D0 (en
GB2328155A (en
Inventor
Antonio Ferrante
Alfred Poulos
Michael Joseph Pitt
Christopher John Easton
Merilyn Joy Sleigh
Deborah Ann Rathjen
Fred Widmer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Womens and Childrens Hospital Adelaide
Teva Pharmaceuticals Australia Pty Ltd
Original Assignee
Womens and Childrens Hospital Adelaide
Peptide Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPN9250A external-priority patent/AUPN925096A0/en
Priority claimed from AUPN9538A external-priority patent/AUPN953896A0/en
Application filed by Womens and Childrens Hospital Adelaide, Peptide Technology Ltd filed Critical Womens and Childrens Hospital Adelaide
Publication of GB9822203D0 publication Critical patent/GB9822203D0/en
Publication of GB2328155A publication Critical patent/GB2328155A/en
Application granted granted Critical
Publication of GB2328155B publication Critical patent/GB2328155B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB9822203A 1996-04-12 1997-04-14 Methods of treating immunopathologies using polyunsaturated fattyacids Expired - Fee Related GB2328155B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPN9250A AUPN925096A0 (en) 1996-04-12 1996-04-12 Methods of treatment
AUPN9538A AUPN953896A0 (en) 1996-04-26 1996-04-26 Treatment of t-cell mediated diseases
PCT/AU1997/000231 WO1997038688A1 (en) 1996-04-12 1997-04-14 Methods of treating immunopathologies using polyunsaturated fattyacids

Publications (3)

Publication Number Publication Date
GB9822203D0 GB9822203D0 (en) 1998-12-02
GB2328155A GB2328155A (en) 1999-02-17
GB2328155B true GB2328155B (en) 2000-08-02

Family

ID=25645159

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9822203A Expired - Fee Related GB2328155B (en) 1996-04-12 1997-04-14 Methods of treating immunopathologies using polyunsaturated fattyacids

Country Status (6)

Country Link
US (1) US6262119B1 (cg-RX-API-DMAC7.html)
EP (1) EP0904072A4 (cg-RX-API-DMAC7.html)
JP (1) JP2000508645A (cg-RX-API-DMAC7.html)
CA (1) CA2251780A1 (cg-RX-API-DMAC7.html)
GB (1) GB2328155B (cg-RX-API-DMAC7.html)
WO (1) WO1997038688A1 (cg-RX-API-DMAC7.html)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2343840C (en) * 1998-10-20 2011-03-08 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Use of a cytokine-producing lactococcus strain to treat colitis
AUPQ291499A0 (en) * 1999-09-17 1999-10-07 Women's And Children's Hospital Adelaide Novel nitro and sulphur containing compounds
NO328803B1 (no) * 2000-03-03 2010-05-18 Thia Medica Nye fettsyreanaloger
ES2381775T3 (es) 2000-08-04 2012-05-31 Dmi Biosciences, Inc. Procedimiento del uso de dicetopiperazinas y composición que las contiene
NO20006008L (no) * 2000-11-28 2002-05-29 Thia Medica As Fettsyreanaloger for behandling av inflammatoriske og autoimmune sykdommer
US7780961B2 (en) * 2001-05-03 2010-08-24 Actogenix N.V. Self-containing Lactococcus strain
US7575929B2 (en) * 2002-10-02 2009-08-18 Dmi Life Sciences, Inc. Diagnosis of multiple sclerosis with diketopiperazines
AU2003298291A1 (en) * 2002-11-15 2004-06-15 Universiteit Gent Self-containing lactobacillus strain
GB0311081D0 (en) * 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
CN101947306B (zh) 2003-05-15 2014-06-18 安皮奥制药股份有限公司 T-细胞介导的疾病的治疗
GB2422373B (en) 2003-08-18 2008-05-21 Btg Int Ltd Treatment of neurodegenerative conditions
DE10351111A1 (de) * 2003-11-03 2005-06-16 Langlotz, Rainer Arzneimittel und Verfahren zu ihrer Herstellung
WO2005073164A1 (en) * 2004-01-30 2005-08-11 Peplin Biolipids Pty Ltd Therapeutic and carrier molecules
US7544714B2 (en) * 2004-07-16 2009-06-09 University Of Massachusetts Lipid-amino acid conjugates and methods of use
GB0425932D0 (en) * 2004-11-25 2004-12-29 Btg Int Ltd Structured phospholipids
GB0504362D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Cytokine modulators
GB0504333D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Treatment of cytokine dysregulation
US20060246115A1 (en) * 2005-03-04 2006-11-02 Ricardo Rueda Nutritional products for ameliorating symptoms of rheumatoid arthritis
US8748126B2 (en) 2005-11-29 2014-06-10 Actogenix N.V. Induction of mucosal tolerance to antigens
EP2125010B1 (en) 2007-01-25 2014-06-04 Actogenix N.V. Treatment of immune disease by mucosal delivery of antigens using genetically modified lactobacillus
EP2120916A4 (en) * 2007-02-05 2010-07-28 Children Youth And Women S Hea MODULATORS FOR THE PROLIFERATION OF T CELLS DEPENDENT OF ANTIGEN
ES2733353T3 (es) 2007-11-09 2019-11-28 Basf As Compuestos lípidos para uso en productos cosméticos, como suplemento alimenticio o como un medicamento
JP5856843B2 (ja) * 2008-05-27 2016-02-10 アンピオ ファーマシューティカルズ，インコーポレイテッド ジケトピペラジンを用いた医薬組成物
EP2147910A1 (en) 2008-07-15 2010-01-27 Pronova BioPharma Norge AS Novel lipid compounds
CN102459142B (zh) 2009-05-08 2017-08-08 普罗诺瓦生物医药挪威公司 用于治疗与心血管、代谢和炎性疾病领域相关的疾病的多不饱和脂肪酸
GB0909643D0 (en) * 2009-06-04 2009-07-22 Avexxin As Glomerulonephritis treatment
GB201014633D0 (en) * 2010-09-02 2010-10-13 Avexxin As Rheumatoid arthritis treatment
US8507496B2 (en) 2010-09-07 2013-08-13 Dmi Acquisition Corp. Treatment of diseases
SG10201509127YA (en) 2010-11-05 2015-12-30 Pronova Biopharma Norge As Methods of treatment using lipid compounds
KR102032400B1 (ko) 2011-10-10 2019-10-15 앰피오 파마슈티컬스 인코퍼레이티드 퇴행성 관절 질환의 치료
EP2765968A4 (en) 2011-10-10 2015-01-21 Ampio Pharmaceuticals Inc IMPLANTABLE MEDICINE PRODUCTS WITH INCREASED IMMUNO TOLERANCE AND PROCESSING AND IMPLANTATION METHODS
SG10201605205VA (en) 2011-10-28 2016-08-30 Ampio Pharmaceuticals Inc Treatment of rhinitis
GB201205394D0 (en) 2012-03-27 2012-05-09 Adlens Ltd Improvements in or relating to deformable non-round membrane assemblies
BR122020006518B1 (pt) 2012-03-30 2022-02-22 Givaudan Sa Composição de sabor
SG11201405413SA (en) 2012-03-30 2014-10-30 Givaudan Sa N-acyl derivatives of gamma amino - butyric acid and and beta alanine as food flavouring compounds
EP2833738B1 (en) 2012-03-30 2019-10-30 Givaudan S.A. N-acylated methionine derivatives as food flavouring compounds
WO2013149031A2 (en) 2012-03-30 2013-10-03 Givaudan S.A. Powder flavour composition
US10711230B2 (en) 2012-03-30 2020-07-14 Givaudan Sa N-acyl proline derivatives as food flavoring compounds
WO2013149008A2 (en) * 2012-03-30 2013-10-03 Givaudan, S.A. Improvements in or relating to organic compounds
BR112014024323B1 (pt) 2012-03-30 2020-03-10 Givaudan Sa Composições compreendendo ácidos 1-aminocicloalquil carboxílicos n-acilados, solução padrão e uso
JP6224072B2 (ja) 2012-03-30 2017-11-01 ジボダン エス エー フレーバープロフィール食用組成物の改良のためのｎ−アシル−アミノ酸誘導体
GB201221329D0 (en) 2012-11-27 2013-01-09 Avexxin As Dermatitis treatment
ES2748562T3 (es) 2013-02-28 2020-03-17 Basf As Una composición que comprende un compuesto lipídico, un triglicérido y un tensioactivo, y procedimientos de uso de la misma
KR20150132508A (ko) 2013-03-15 2015-11-25 앰피오 파마슈티컬스 인코퍼레이티드 줄기세포의 가동화, 회귀, 증식 및 분화를 위한 조성물 및 이의 사용 방법
US10537127B2 (en) 2013-10-02 2020-01-21 Givaudan S.A. Organic compounds
EP3052472B1 (en) 2013-10-02 2019-02-27 Givaudan S.A. N-acylated 2-aminoisobutyric acid compounds and flavour compositions containing them
EP3057444B1 (en) 2013-10-02 2017-12-06 Givaudan SA Organic compounds having taste-modifying properties
WO2015050535A1 (en) 2013-10-02 2015-04-09 Givaudan S.A. Organic compounds
GB201317424D0 (en) 2013-10-02 2013-11-13 Givaudan Sa Improvements in or relating to organic compounds
EP3057447B1 (en) 2013-10-02 2017-12-06 Givaudan S.A. Organic compounds having taste-modifying properties
WO2015050534A1 (en) 2013-10-02 2015-04-09 Givaudan S.A. Organic compounds
GB201409363D0 (en) 2014-05-27 2014-07-09 Avexxin As Skin cancer treatment
EP4066836A1 (en) 2014-08-18 2022-10-05 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
CN107530306A (zh) 2015-04-28 2018-01-02 普罗诺瓦生物医药挪威公司 结构增强的含硫脂肪酸在预防和/或治疗非酒精性脂肪性肝炎中的用途
EP3310375A4 (en) 2015-06-22 2019-02-20 Ampio Pharmaceuticals, Inc. USE OF LOW-MOLECULAR FRACTIONS OF HUMAN SERUMALBUMINE IN THE TREATMENT OF ILLNESSES
WO2017156164A1 (en) 2016-03-09 2017-09-14 Board Of Regents, The University Of Texas System 20-hete receptor (gpr75) antagonists and methods of use
GB201604316D0 (en) 2016-03-14 2016-04-27 Avexxin As Combination therapy
KR20190055153A (ko) 2016-09-21 2019-05-22 아벡신 에이에스 약학 조성물
IL275002B2 (en) 2017-12-06 2024-04-01 Basf As Fatty acid derivatives for treating non-alcoholic steatohepatitis

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993000326A1 (de) * 1991-06-25 1993-01-07 Basf Aktiengesellschaft Omega-3 mehrfach ungesättigte fettsäurederivate, ihre herstellung und verwendung
EP0582834A1 (en) * 1992-08-11 1994-02-16 Prospa B.V. Pharmaceutical compositions containing esters of omega-3 polyunsatured acids and their use in the topical treatment of morbid affections
AU3156595A (en) * 1994-08-11 1996-03-07 J.W. Broadbent Nominees Pty. Ltd. Anti-inflammatory preparation
AU3645195A (en) * 1994-10-13 1996-05-06 Children, Youth And Women's Health Service Incorporated Modified polyunsaturated fatty acids
AU3765895A (en) * 1994-10-26 1996-05-23 Children, Youth And Women's Health Service Incorporated Synthetic polyunsaturated fatty acid analogues
US5585400A (en) * 1996-02-27 1996-12-17 Wisconsin Alumni Research Foundation Methods of attenuating the allergic response in animals
US5616607A (en) * 1993-03-29 1997-04-01 Hsc Research And Development Limited Partnership Hepoxilin analogs

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK435087A (da) * 1986-09-10 1988-03-11 Hoffmann La Roche Isoprenderivater
JPS6372648A (ja) * 1986-09-16 1988-04-02 Sumitomo Pharmaceut Co Ltd 新規不飽和脂肪酸誘導体
JPH02225411A (ja) * 1989-02-28 1990-09-07 Nippon Oil & Fats Co Ltd 高度不飽和脂肪酸の溶血性低下方法
US5202456A (en) * 1991-04-15 1993-04-13 The President And Fellows Of Harvard College Compounds for inhibition of protein methylation
US5618955A (en) * 1992-11-30 1997-04-08 Yissum Research Development Company Of The Hebrew University Of Jerusalem Fatty acid derivatives and pharmaceutical compositions containing same
AUPM740594A0 (en) 1994-08-11 1994-09-01 J.W. Broadbent Nominees Pty. Ltd. Anti-inflammatory preparation
EP0869941B1 (en) * 1994-10-13 2001-12-12 Peptech Limited Modified polyunsaturated fatty acids
AUPM906594A0 (en) 1994-10-26 1994-11-17 Peptide Technology Limited Synthetic polyunsaturated fatty acid analogues
MY118354A (en) * 1995-05-01 2004-10-30 Scarista Ltd 1,3-propane diol derivatives as bioactive compounds

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993000326A1 (de) * 1991-06-25 1993-01-07 Basf Aktiengesellschaft Omega-3 mehrfach ungesättigte fettsäurederivate, ihre herstellung und verwendung
EP0582834A1 (en) * 1992-08-11 1994-02-16 Prospa B.V. Pharmaceutical compositions containing esters of omega-3 polyunsatured acids and their use in the topical treatment of morbid affections
US5616607A (en) * 1993-03-29 1997-04-01 Hsc Research And Development Limited Partnership Hepoxilin analogs
AU3156595A (en) * 1994-08-11 1996-03-07 J.W. Broadbent Nominees Pty. Ltd. Anti-inflammatory preparation
AU3645195A (en) * 1994-10-13 1996-05-06 Children, Youth And Women's Health Service Incorporated Modified polyunsaturated fatty acids
AU3765895A (en) * 1994-10-26 1996-05-23 Children, Youth And Women's Health Service Incorporated Synthetic polyunsaturated fatty acid analogues
US5585400A (en) * 1996-02-27 1996-12-17 Wisconsin Alumni Research Foundation Methods of attenuating the allergic response in animals

Also Published As

Publication number Publication date
EP0904072A4 (en) 2003-07-30
GB9822203D0 (en) 1998-12-02
CA2251780A1 (en) 1997-10-23
EP0904072A1 (en) 1999-03-31
GB2328155A (en) 1999-02-17
US6262119B1 (en) 2001-07-17
WO1997038688A1 (en) 1997-10-23
JP2000508645A (ja) 2000-07-11

Similar Documents

Publication Publication Date Title
GB2328155B (en) Methods of treating immunopathologies using polyunsaturated fattyacids
ZA977902B (en) Fatty acid treatment
ZA977564B (en) Method of treatment
IL127421A0 (en) Process to prepare aryldiphosphoric esters
GB9605828D0 (en) Treatment method
GB2326952B (en) Method of providing microscopic features
GB9607609D0 (en) Cable treatment
GB9506837D0 (en) Triglycerides
GB9621373D0 (en) Fatty acid treatment
SG64990A1 (en) Method of treating polyolefin
PL313419A1 (en) Method of obtaining beta-naphtole
ZA973988B (en) Method of treatment
GB9618341D0 (en) Method of treatment
AU2498897A (en) Methods of treating immunopathologies using polyunsaturated fatty acids
HU9602005D0 (en) Cable and method for making said cable and use of said cable
KR100221732B1 (en) Reformative method of welding structure object
TW297472U (en) Structural of nut
TW310785U (en) Structural improvement of anti-loosing nut
TW296153U (en) Improved structure of separable clamp
GB9602404D0 (en) Methods of treatment
GB9600888D0 (en) Method of treatment
PL303296A1 (en) Method of examining power lines
GB9621294D0 (en) Fatty acid treatment
TW312971U (en) Improved brake structure of walk-assisting apparatus
TW297219U (en) Structure of clamp

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20110414